Oppenheimer & CO Inc Novo Nordisk A S Transaction History

Oppenheimer & CO Inc

  • $6.42 Billion
  • Q3 2024

A detailed history of Oppenheimer & CO Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Oppenheimer & CO Inc holds 147,376 shares of NVO stock, worth $15.9 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares
147,376
Previous 164,348 10.33%
Holding current value
$15.9 Million
Previous $23.5 Million 25.2%
% of portfolio
0.27%
Previous 0.38%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024
SELL
$119.07 - $145.42 $2.02 Million - $2.47 Million
-16,972 Reduced 10.33%
147,376 $17.5 Million
Q2 2024

Aug 07, 2024
SELL
$122.71 - $146.91 $334,384 - $400,329
-2,725 Reduced 1.63%
164,348 $23.5 Million
Q1 2024

May 06, 2024
BUY
$102.11 - $135.92 $2.76 Million - $3.67 Million
27,005 Added 19.28%
167,073 $21.5 Million
Q4 2023

Feb 13, 2024
BUY
$87.78 - $105.45 $1.41 Million - $1.7 Million
16,110 Added 13.0%
140,068 $14.5 Million
Q3 2023

Nov 07, 2023
BUY
$90.94 - $199.54 $5.83 Million - $12.8 Million
64,091 Added 107.06%
123,958 $11.3 Million
Q2 2023

Aug 02, 2023
BUY
$155.98 - $172.65 $443,919 - $491,361
2,846 Added 4.99%
59,867 $9.69 Million
Q1 2023

May 10, 2023
BUY
$132.34 - $159.14 $54,656 - $65,724
413 Added 0.73%
57,021 $9.07 Million
Q4 2022

Feb 07, 2023
SELL
$102.55 - $135.33 $400,970 - $529,140
-3,910 Reduced 6.46%
56,608 $7.66 Million
Q3 2022

Nov 14, 2022
SELL
$95.28 - $116.93 $380,453 - $466,901
-3,993 Reduced 6.19%
60,518 $6.03 Million
Q2 2022

Aug 08, 2022
SELL
$103.24 - $121.81 $330,368 - $389,792
-3,200 Reduced 4.73%
64,511 $7.19 Million
Q1 2022

May 12, 2022
BUY
$93.1 - $112.54 $45,246 - $54,694
486 Added 0.72%
67,711 $7.52 Million
Q4 2021

Feb 02, 2022
BUY
$95.88 - $117.08 $98,468 - $120,241
1,027 Added 1.55%
67,225 $7.53 Million
Q3 2021

Nov 12, 2021
SELL
$84.42 - $106.62 $1.08 Million - $1.36 Million
-12,738 Reduced 16.14%
66,198 $6.36 Million
Q2 2021

Aug 03, 2021
SELL
$67.66 - $84.76 $605,421 - $758,432
-8,948 Reduced 10.18%
78,936 $6.61 Million
Q1 2021

May 10, 2021
SELL
$67.06 - $75.82 $12,070 - $13,647
-180 Reduced 0.2%
87,884 $5.93 Million
Q4 2020

Feb 11, 2021
BUY
$63.89 - $73.8 $1.58 Million - $1.82 Million
24,713 Added 39.01%
88,064 $6.15 Million
Q3 2020

Nov 13, 2020
BUY
$63.69 - $70.22 $1.28 Million - $1.41 Million
20,112 Added 46.51%
63,351 $4.4 Million
Q2 2020

Aug 11, 2020
SELL
$58.54 - $67.94 $73,818 - $85,672
-1,261 Reduced 2.83%
43,239 $2.83 Million
Q1 2020

May 08, 2020
SELL
$49.46 - $64.78 $147,192 - $192,785
-2,976 Reduced 6.27%
44,500 $2.68 Million
Q4 2019

Feb 07, 2020
SELL
$49.86 - $58.26 $85,360 - $99,741
-1,712 Reduced 3.48%
47,476 $2.75 Million
Q3 2019

Oct 31, 2019
BUY
$47.54 - $53.43 $9,555 - $10,739
201 Added 0.41%
49,188 $2.54 Million
Q2 2019

Aug 09, 2019
SELL
$46.79 - $52.47 $160,302 - $179,762
-3,426 Reduced 6.54%
48,987 $2.5 Million
Q1 2019

Apr 24, 2019
SELL
$46.36 - $52.63 $513,158 - $582,561
-11,069 Reduced 17.44%
52,413 $2.74 Million
Q4 2018

Jan 29, 2019
SELL
$41.54 - $47.25 $116,062 - $132,016
-2,794 Reduced 4.22%
63,482 $2.93 Million
Q3 2018

Oct 26, 2018
SELL
$46.76 - $51.24 $916,776 - $1 Million
-19,606 Reduced 22.83%
66,276 $3.13 Million
Q2 2018

Aug 10, 2018
SELL
$44.29 - $50.42 $44,954 - $51,176
-1,015 Reduced 1.17%
85,882 $3.96 Million
Q1 2018

May 01, 2018
BUY
$48.49 - $58.14 $879,463 - $1.05 Million
18,137 Added 26.38%
86,897 $4.28 Million
Q4 2017

Feb 07, 2018
SELL
$47.53 - $53.73 $9,601 - $10,853
-202 Reduced 0.29%
68,760 $3.69 Million
Q3 2017

Nov 09, 2017
BUY
$41.15 - $49.22 $2.84 Million - $3.39 Million
68,962
68,962 $3.32 Million

Others Institutions Holding NVO

# of Institutions
1,956
Shares Held
320M
Call Options Held
5.49M
Put Options Held
7.78M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $244B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Oppenheimer & CO Inc Portfolio

Follow Oppenheimer & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer & CO Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email